Medical Science News

RSS

Like father, like son? Study reveals a surprising pattern in male reproductive health

Researchers examining 117 father-son pairs from Denmark and Finland identified weak but statistically significant familial associations in several male reproductive traits, including testicular size, sperm concentration, selected hormone levels, and genital measurements. The findings suggest that reproductive characteristics show limited resemblance across generations, although the study could not determine the relative contributions of genetic and environmental factors.

21 Oct 2026

Beef can fit into healthy diets, but what about its environmental cost?

A narrative review published in Animal Frontiers highlights beef's contribution to high-quality protein and bioavailable micronutrients, while controlled trials generally found no adverse effects on selected cardiometabolic risk markers, although long-term disease outcomes remain uncertain. The authors argue that sustainable food policies should consider nutritional needs, environmental impacts, agricultural productivity, and rural livelihoods when evaluating beef's place in healthy diets.

21 Oct 2026

Semaglutide and teduglutide reduce immune-driven gut injury in mice

Researchers found that gut-derived GLP-1 and GLP-2 signaling helped protect mice against T cell-induced intestinal injury, with GLP-1R primarily regulating inflammation and GLP-2R supporting intestinal repair. Semaglutide and teduglutide, administered separately or together, reduced acute intestinal damage in mice lacking intestinal proglucagon, suggesting potential avenues for investigating treatments for immune-mediated gut injury.

21 Oct 2026

Blocking specific proteins protects beta cells om excessive cellular stress

Researchers at Weill Cornell Medicine have identified a molecular pathway that contributes to the death of insulin-producing beta cells in the pancreas.

21 Oct 2026

Glucose priming may improve tumor targeting for chemotherapy nanocarriers

Chemotherapy selectivity is limited by systemic toxicity. pH‑sensitive nanocarriers exploit tumor acidity as a release trigger but respond passively to a modest, heterogeneous gradient.

21 Oct 2026

Study identifies new genetic factors underlying fat accumulation in the liver

Researchers at Karolinska Institutet have identified additional genetic factors underlying fat accumulation in the liver.

21 Oct 2026

Altered fatty acid metabolism drives glioblastoma growth and treatment resistance

Glioma is the most common primary malignant brain tumor in adults, and glioblastoma (GBM), particularly IDH (Isocitrate dehydrogenase)-wildtype disease, has the poorest prognosis.

21 Oct 2026

Greenwood Genetic Center researcher wins major grant to explore cellular metabolism and glycosylation

Heather Flanagan-Steet, PhD, Associate Director of Research at the Greenwood Genetic Center (GGC), has received a $1.4 million, five-year Maximizing Investigators' Research Award (MIRA) R35 grant from the National Institutes of Health's National Institute of General Medical Sciences.

21 Oct 2026

Cell Painting method reveals drug differences in 3D cancer cells

Researchers at Uppsala University have adapted Cell Painting, a widely used imaging method in drug discovery, to look at individual cells inside small 3D clusters of cancer cells.

21 Oct 2026

Cold-water immersion lacks superiority for recovering muscle strength

Cold-water immersion is a popular post-workout recovery strategy, but new research suggests it may offer no greater benefit to muscle strength recovery than heat-based methods.

21 Oct 2026

Biological framework tracks postpartum vulvar tissue recovery timelines

A new biological model published in Sexual Medicine Reviews by Oxford University Press addresses why pain with sex after childbirth-reported by 60% of women at three months-persists for some long after hormones return to normal.

21 Oct 2026

Oxaloacetate supplement may help reduce chemo brain in breast cancer survivors

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that a nutritional supplement containing oxaloacetate, a molecule naturally found in the body that helps cells produce energy, may help improve cognitive function and reduce the fatigue experienced by some breast cancer survivors following treatment.

21 Oct 2026

Qureight appointed imaging CRO for Phase 3 SURPASS-IPF trial as partnership with Celea Therapeutics expands

Qureight, an end-to-end imaging CRO providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, today announced it has been selected by Celea Therapeutics as the imaging CRO to support Celea’s Phase 3 SURPASS-IPF clinical trial.

From Qureight 21 Oct 2026